# Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

> **NCT01352117** · PHASE3 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 192 (actual)

## Conditions studied

- HIV-1 Infection
- Kaposi's Sarcoma

## Interventions

- **DRUG:** efavirenz/emtricitabine/tenofovir disoproxil fumarate
- **DRUG:** etoposide

## Key facts

- **NCT ID:** NCT01352117
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-18
- **Primary completion:** 2016-03-16
- **Final completion:** 2018-11-29
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2019-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352117, "Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01352117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*